For over 40 years, Butterworth Laboratories has provided independent, contract analytical services to the global pharmaceutical and related industries.
Excipients play a fundamental role in API delivery, and John Welch, Butterworth’s Associate Director of Business Operations, believes that their testing is key to ensuring the safety of pharmaceutical products
In the pharmaceutical industry, excipients can make up as much as 90% of a drug product, meaning their quality and safety are just as crucial as that of APIs. The misconception that excipients are “inactive” can lead to overlooking potential risks, such as contamination from impurities or recycled solvents.
To read the full article published in Manufacturing Chemist, click here.